Ikarian Capital’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
Other funds holding VTGN
Ikarian Capital's VTGN Position: Q3 2026 in Review
Ikarian Capital held its VistaGen Therapeutics (VTGN) position steady in Q3 2026 at 519,077 shares worth $160K. The position accounts for 0.02% of the portfolio, ranked #161.
Ikarian Capital first reported a position in VTGN in Q4 2020 and has held it in 15 quarters since. The position peaked at $8.7M in Q4 2020. 42 funds tracked by Wall St. Rank hold VTGN as of Q3 2026.
- Ikarian Capital held 519,077 shares of VistaGen Therapeutics worth $160K as of Q3 2026.
- Ikarian Capital left its VistaGen Therapeutics share count unchanged in Q3 2026.
- VistaGen Therapeutics made up 0.02% of Ikarian Capital's portfolio in Q3 2026, its #161 holding.
- Ikarian Capital first reported a position in VistaGen Therapeutics in Q4 2020 and has held it in 15 quarters since.
- Ikarian Capital's VistaGen Therapeutics position peaked at $8.7M in Q4 2020.
- 42 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q3 2026.
Based on Ikarian Capital's 13F filing for Q3 2026, filed 16 Nov 2026.